Made from Natural Brown Algae, scientifically proven for its Wound Healing capabilities. Soft, easily Conforms to any wound bed including cavities.

Assists in Accelerated Wound Healing. Available in two formats, KOTSZR CA+(for mild exuding wounds) & KOTSZR CA+extra (for moderate to high exuding wounds).

Key Features

More Comfortable

Exceptionally Soft

Rapid Gel Formation

High Absorbency of
Wound Exudate

Trapping of Bacteria and
Cell Debris

Ease conforms to any
wound bed

Mechanism of Action

KOTSZR dressings impress with their high exudate absorbing capacity and quick gel formation from the exchange of ions.

Ion-Exchange Causing Quick Gel Formation

Excess exudate from the wound is absorbed into the dressing, therefore maintaining optimum moisture for wound healing.

Optimum Moisture Maintenance

Ca⁺ ions present in KOTSZR dressings promote haemostasis by directly playing a role in the clotting mechanism.

Ca+ ions Promote Haemostasis

Calcium Alginate in KOTSZR dressings promote the growth of fibroblasts and also up-regulatesthe ratio of collagen typesI/III which in turn promotes granulation and re-epithelization.

Calcium Alginate Accelerates Healing

Use Cases

Indicated for use on wounds that are Infected or are at Risk of Infection.

Venous Leg Ulcer

Burns

Pressure Ulcer

Cavity Wound

Donor Site

Ulcer

How to use?

Always use the Aseptic Technique

Clean and Irrigate the Wound

Folding make sure it fits the Wound

Apply a Secondary Dressing

Irrigate with Saline and Gently Peel Off

Remove the dressing Slowly and Discard It

Clinical Data

Absorbency

KOTSZR dressings, have demonstrated greater absorbency compared to other commercially available brands.
Good Exudate Management promotes positive healing progression of the wound.

Tensile Strength

• KOTSZR dressings show 5x more strength when compared to other commercially available brands.

• It aids in better ease of application at the wound site.

Wet Tensile Strength

KOTSZR dressings have significantly higher wet tensile strength when compared to other commercially available brands.
It aids in easy, trauma-free removal of dressings from wound site.

A – Urgosorb ® Silver/Ag is a registered trademark of URGO Medical | B – ALGISITE Ag is a registered trademark of Smith & Nephew
C – Biatain® Ag is a registered trademark of Coloplast | D – Sorbalgon® Ag is a registered trademark of Paul Hartmann E – SILVERCEL is a registered trademark of 3M|KCI

Product Information

Product – KOTSZR CA

Product Code	Size	Items
KZCA0510	5×10	10
KZCA1010	10×10	10
KZCA1515	15×15	10
KZCA1020	10×20	10
KZCA1520	15×20	10
KZCA0230	2×30	5
KZCA3060	30×60	5

Product – KOTSZR CA+

Product Code	Size	Items
KZCAP0510	5×10	10
KZCAP1010	10×10	10
KZCAP1515	15×15	10
KZCAP1020	10×20	10
KZCAP1520	15×20	10
KZCAP0230	2×30	5
KZCAP3060	30×60	5

Product – KOTSZR CA+extra

Product Code	Size	Items
KZCAPX0510	5×10	10
KZCAPX1010	10×10	10
KZCAPX1515	15×15	10
KZCAPX1020	10×20	10
KZCAPX1520	15×20	10
KZCAPX0230	2×30	5
KZCAPX3060	30×60	5

Show References

References*

Timmons J. Alginate and hydrofiber dressings. Professional Nurse 1999;14(7).
http://www.worldwidewounds.com/1998/june/Alginates-FAQ/alginates-questions.html
Segal HC et al. The effects of alginate and non-alginate wound dressings on blood coagolation and platelet activation. Journal of Biomaterials Applications 1998;249-57.
Elalamy I and Robert F. Etude in vitro des effets proactivateurs plaquettaires de deux pansements: Alginate pur (Algostéril) et Alginate-CMC (SeaSorb Soft), etude sur plasma riche en plaquettes. CPC France 2007.
Van Dam, Ria (2009): The treatment of infected wounds of older patients with a silver alginate. Poster presented at EWMA 2009. Helsinki, Finland, 20.05.2009
Dol, Lucienne (2009): A treatment of stagnate abdominal wounds after bowel surgery. Poster presented at EWMA 2009. Helsinki, Finland, 20.05.2009.
Wiegand, Ruth, Abel, Schonfelder, Elsner and Hipler. Influence of alginate and silver containing alginate on elastase and ROS activity in-vitro. Experimental Dermatology 16 194-295
Wiegand, Abel, Ruth, Hipler, comparison of the antimicrobial effect of PHMB and silver containing wound dressings using different in-vitro methods. Poster presented at EWMA 25-27th May 2011.
Wiegand, Ruth, Abel, Gorka, Elsner and Hipler. Influence of alginate and silver containing alginate on elastase and ROS activity as well as TNF-α concentration in-vitro. Poster presented at CPC Paris 27-29 January 2008
Wiegand. Heinze, Hipler. Comparative in-vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver containing alginate.
Case reports presented in L&R Suprasorb A+Ag PCMF